Volume 96, Issue 5, November 2012
Including PIH Articles on Current and Future Management of Major Subtypes of Malignant Lymphoma Based on Clinical Trials
ISSN: 0925-5710 (Print) 1865-3774 (Online)
In this issue (21 articles)
-
Images in Hematology
Huge multinucleated megaloblasts found in a patient with refractory anemia with excess blasts-1
Pages 531-532 -
Progress in Hematology
Guest editorial: Management of malignant lymphoma is continuously improving
Pages 533-534 -
Progress in Hematology
Advances in the treatment of Hodgkin lymphoma
Pages 535-543 -
Progress in Hematology
Current and future management of follicular lymphoma
Pages 544-551 -
Progress in Hematology
Diffuse large B cell lymphoma: molecular targeted therapy
Pages 552-561 -
Progress in Hematology
Current and future management of NK/T-cell lymphoma based on clinical trials
Pages 562-571 -
Review Article
P2Y12 receptor: platelet thrombus formation and medical interventions
Pages 572-587 -
Original Article
Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals
Pages 588-593 -
Original Article
Role of CD61+ cells in thrombocytopenia of dengue patients
Pages 600-610 -
Original Article
The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
Pages 611-616 -
Original Article
Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells
Pages 649-656
Continue reading...
To view the rest of this content please follow the download PDF link above.